News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

In Search For Alzheimer's Drug, A Major STEP Forward, Yale University School Of Medicine Study


8/6/2014 7:04:05 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Researchers at Yale School of Medicine have discovered a new drug compound that reverses the brain deficits of Alzheimer's disease in an animal model. Their findings are published in the Aug. 5 issue of the journal PLoS Biology. The compound, TC-2153, inhibits the negative effects of a protein called STtriatal-Enriched tyrosine Phosphatase (STEP), which is key to regulating learning and memory. These cognitive functions are impaired in Alzheimer's.

Hey, check out all the research scientist jobs. Post your resume today!

Read at EurekAlert!
Read at News Release
Read at ScienceDaily


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES